The trajectory of Sildenafil presents a complex case for investors in the drug sector. While initially a blockbuster success, producing vast sums, the patent lapse and the subsequent arrival of off-brand alternatives https://gambling876055.blogmazing.com/40565791/the-little-copyright-and-pharma-a-speculative-play